Skip to main content
. 2011 Mar;13(1):127–138. doi: 10.31887/DCNS.2011.13.1/rjoffe

Table VI. Testosterone treatment of depression.

Study Subjects Design Testosterone Antidepressant Result
Seidman and Rabkin, 199866 5 men Low testosterone levels Open 8 weeks 400 mg im biweekly Yes Marked improvement
Seidman et al, 200167 32 men Hypogonadal RCT 6 weeks 200 mg im q-weekly Yes Testosterone=Placebo
Perry et al, 200268 16 Older males Open 6 weeks 200 mg vs 100 mg qweekly No No dose effect Improvement late onset > early onset depression
Pope et al, 200369 22 Low testosterone levels RCT 8 weeks Gel 1% 10 g/day Yes Testosterone>placebo
Orengo et al, 200570 61 Hypogonadal men >50 y RCT 12-week crossover Gel 1% 5 g/day Yes Testosterone=placebo
Seidman et al, 200571 26 Healthy adult men RCT 6 weeks im Yes Testosterone=placebo
Seidman et al, 200972 23 Men, low testosterone Dysthymic RCT 6 xeeks im q 10 days No Testosterone>placebo
Shores et al, 200973 33 Men >50 y hypogonadal Dysthymic RCT 12 weeks Gel 1% 7.5 g/day Yes Testosterone>placebo
Pope et al, 201074 100 Adulte men Low testosterone levels RCT 6 weeks Gel 1 % Yes Testosterone=placebo